Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Baigent C.,,"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients",2002,British Medical Journal,5881,,United Kingdom,Article,Oxford,0,Journal,2-s2.0-0037065502
Rozic J.,,"Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis",2001,International Journal of Cancer,206,10.1002/ijc.1376,Canada,Article,London,0,Journal,2-s2.0-0035882534
FitzGerald G.,,"The coxibs, selective inhibitors of cyclooxygenase-2",2001,New England Journal of Medicine,1333,10.1056/NEJM200108093450607,United States,Review,Philadelphia,0,Journal,2-s2.0-0035833502
Patrono C.,,Cyclooxygenase-selective inhibition of prostanoid formation: Transducing biochemical selectivity into clinical read-outs,2001,Journal of Clinical Investigation,241,10.1172/JCI200113418,Italy,Review,Chieti,1,Journal,2-s2.0-0034946873
Howe H.,,"Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends",2001,Journal of the National Cancer Institute,641,10.1093/jnci/93.11.824,United States,Article,Springfield,1,Journal,2-s2.0-0035815923
Khuder S.,,Breast cancer and NSAID use: A meta-analysis,2001,British Journal of Cancer,232,10.1054/bjoc.2000.1709,United States,Article,Toledo,1,Journal,2-s2.0-0035805054
Oshima M.,,"Chemoprevention of intestinal polyposis in the Apc<sup>Δ716</sup>mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor",2001,Cancer Research,337,,Japan,Article,Tokyo,0,Journal,2-s2.0-0035866401
Marx J.,,Anti-inflammatories inhibit cancer growth - But how?,2001,Science,101,10.1126/science.291.5504.581,,Short Survey,,0,Journal,2-s2.0-0035951493
Liu C.,,Overexpression of Cyclooxygenase-2 is Sufficient to Induce Tumorigenesis in Transgenic Mice,2001,Journal of Biological Chemistry,705,10.1074/jbc.M010787200,United States,Article,Farmington,1,Journal,2-s2.0-0035947709
Sumitani K.,,Specific inhibition of cyclooxygenase-2 results in inhibition of proliferation of oral cancer cell lines via suppression of prostaglandin E<inf>2</inf> production,2001,Journal of Oral Pathology and Medicine,96,10.1034/j.1600-0714.2001.300107.x,Japan,Article,Tokyo,0,Journal,2-s2.0-0035173913
Kokawa A.,,Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors,2001,Cancer,175,10.1002/1097-0142(20010115)91:2<333::AID-CNCR1006>3.0.CO;2-N,Japan,Article,Chuo-ku,1,Journal,2-s2.0-0035863223
García Rodríguez L.,,Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs,2001,Epidemiology,293,10.1097/00001648-200101000-00015,Spain,Article,Madrid,0,Journal,2-s2.0-0035183413
Patrono C.,,"Platelet-active drugs: The relationships among dose, effectiveness, and side effects",2001,Chest,484,10.1378/chest.119.1_suppl.39S,,Article,,0,Journal,2-s2.0-0035124920
Greenlee R.,,"Cancer Statistics, 2001",2001,Ca-A Cancer Journal for Clinicians,3223,10.3322/canjclin.51.1.15,United States;United States,Article,Marshfield;Atlanta,1,Journal,2-s2.0-0035114558
Shureiqi I.,,15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells,2000,Cancer Research,176,,United States,Article,Houston,0,Journal,2-s2.0-0034671921
Calaluce R.,,Effects of piroxicam on prostaglandin E<inf>2</inf> levels in rectal mucosa of adenomatous polyp patients: A randomized phase IIb trial<sup>1</sup>,2000,Cancer Epidemiology Biomarkers and Prevention,26,,United States,Article,Tucson,0,Journal,2-s2.0-0034518957
Uefuji K.,,"Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines",2000,Anticancer Research,39,,Japan,Article,Tokorozawa,0,Journal,2-s2.0-0034477132
Yao R.,,Inhibition of COX-2 and induction of apoptosis: Two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis,2000,Experimental Lung Research,69,10.1080/01902140150216783,United States,Conference Paper,Columbus,0,Journal,2-s2.0-0034525705
Bombardier C.,,Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis,2000,New England Journal of Medicine,3534,10.1056/NEJM200011233432103,Canada;Canada,Article,Toronto;Toronto,0,Journal,2-s2.0-0034707105
Tsubouchi Y.,,Meloxicam inhibits the growth of non-small cell lung cancer,2000,Anticancer Research,88,,Japan,Article,Kyoto,0,Journal,2-s2.0-0033790479
Williams C.,,Celecoxib prevents tumor growth in vivo without toxicity to normal gut: Lack of correlation between in vitro and in vivo models,2000,Cancer Research,309,,United States,Article,Nashville,0,Journal,2-s2.0-0034326837
Tavani A.,,Aspirin and ovarian cancer: An italian case-control study,2000,Annals of Oncology,78,10.1023/A:1008373616424,Italy,Article,Milan,1,Journal,2-s2.0-0033784786
Grubbs C.,,Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats,2000,Cancer Research,251,,United States,Article,Birmingham,0,Journal,2-s2.0-0034667354
Souza R.,,Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells,2000,Cancer Research,295,,United States;United States,Article,Dallas;Dallas,0,Journal,2-s2.0-0034667497
Cao Y.,,Intracellular unesterified arachidonic acid signals apoptosis,2000,Proceedings of the National Academy of Sciences of the United States of America,363,10.1073/pnas.200367597,United States,Article,Salt Lake City,1,Journal,2-s2.0-0034633638
Jacoby R.,,The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis,2000,Cancer Research,425,,United States,Article,Madison,0,Journal,2-s2.0-0034665122
Gupta R.,,Combinations for cancer prevention,2000,Nature Medicine,50,10.1038/79664,United States,Article,Nashville,0,Journal,2-s2.0-0033835321
Joki T.,,"Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398",2000,Cancer Research,246,,United States,Article,Boston,0,Journal,2-s2.0-0034282530
Torrance C.,,Combinatorial chemoprevention of intestinal neoplasia,2000,Nature Medicine,464,10.1038/79534,United States,Article,Baltimore,0,Journal,2-s2.0-0033827119
García Rodríguez L.,,Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: A pooled analysis of published studies and a new population-based study,2000,Epidemiology,112,10.1097/00001648-200007000-00003,Spain,Article,Madrid,0,Journal,2-s2.0-0033935875
Jänne P.,,Chemoprevention of colorectal cancer,2000,New England Journal of Medicine,410,10.1056/NEJM200006293422606,,Review,,0,Journal,2-s2.0-0038543824
Steinbach G.,,"The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis",2000,New England Journal of Medicine,2159,10.1056/NEJM200006293422603,United States,Article,Houston,0,Journal,2-s2.0-17744418769
Langman M.J.S.,,Effect of anti-inflammatory drugs on overall risk of common cancer: Case-control study in general practice research database,2000,British Medical Journal,399,10.1136/bmj.320.7250.1642,United Kingdom,Article,Birmingham,1,Journal,2-s2.0-0034679222
Li M.,,Aspirin induction of apoptosis in esophageal cancer: A potential for chemoprevention,2000,Cancer Epidemiology Biomarkers and Prevention,97,,United States,Article,Houston,0,Journal,2-s2.0-0034130336
Harris R.,,"Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor",2000,Cancer Research,457,,United States;United States,Article,Columbus;Columbus,0,Journal,2-s2.0-0034655238
Coogan P.,,NSAIDs and risk of colorectal cancer according to presence or absence of family history of the disease,2000,Cancer Causes and Control,51,10.1023/A:1008931708716,United States,Note,Boston,0,Journal,2-s2.0-0034124321
Afford S.,,Apoptosis,2000,Journal of Clinical Pathology - Molecular Pathology,144,10.1136/mp.53.2.55,United Kingdom,Review,Birmingham,1,Journal,2-s2.0-0034037470
Chow H.,,Effect of subacute ibuprofen dosing on rectal mucosal prostaglandin E<inf>2</inf> levels in healthy subjects with a history of resected polyps,2000,Cancer Epidemiology Biomarkers and Prevention,11,,United States,Article,Tucson,0,Journal,2-s2.0-0034101836
Gibbs J.,,Mechanism-based target identification and drug discovery in cancer research,2000,Science,413,10.1126/science.287.5460.1969,United States,Review,Kenilworth,0,Journal,2-s2.0-0034677755
Wu G.,,A nuclear receptor to prevent colon cancer,2000,New England Journal of Medicine,40,10.1056/NEJM200003023420909,United States,Article,Philadelphia,0,Journal,2-s2.0-0034594870
Masferrer J.L.,,Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors,2000,Cancer Research,1241,,United States,Article,New York,0,Journal,2-s2.0-0034161878
Willoughby D.,,"COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease",2000,Lancet,257,10.1016/S0140-6736(99)12031-2,United Kingdom,Note,London,0,Journal,2-s2.0-0034685192
Reddy B.,,"Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis",2000,Cancer Research,438,,United States,Article,New York,0,Journal,2-s2.0-0034650771
Breuer-Katschinski B.,,Long-term use of nonsteroidal antiinflammatory drugs and the risk of colorectal adenomas,2000,Digestion,38,10.1159/000007745,,Article,,0,Journal,2-s2.0-0034004226
Prescott S.M.,,Is cyclooxygenase-2 the alpha and the omega in cancer?,2000,Journal of Clinical Investigation,88,10.1172/JCI10241,United States,Note,Salt Lake City,1,Journal,2-s2.0-0034080252
Nakatsugi S.,,"Chemoprevention by nimesulide, a selective cyclooxygenase-2 inhibitor, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary gland carcinogenesis in rats",2000,Japanese Journal of Cancer Research,108,10.1111/j.1349-7006.2000.tb01030.x,Japan;Japan,Article,Chuo-ku;Osaka,1,Journal,2-s2.0-0033778451
Alshafie G.A.,,"Chemotherapeutic evaluation of Celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model",2000,Oncology Reports,147,10.3892/or.7.6.1377,United States,Article,Columbus,0,Journal,2-s2.0-0034320268
Sharpe C.R.,,Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage,2000,British Journal of Cancer,153,10.1054/bjoc.2000.1119,Canada;Canada,Article,Montreal;Montreal,1,Journal,2-s2.0-0034039306
Castelao J.E.,,Non-steroidal anti-inflammatory drugs and bladder cancer prevention,2000,British Journal of Cancer,192,10.1054/bjoc.1999.1106,United States,Article,Los Angeles,1,Journal,2-s2.0-0034112881
Liu X.H.,,Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo,2000,Journal of Urology,343,10.1016/s0022-5347(05)67321-1,United States,Article,New York,0,Journal,2-s2.0-0001501848
Williams C.,,Host cyclooxygenase-2 modulates carcinoma growth,2000,Journal of Clinical Investigation,634,10.1172/JCI9621,United States;United States,Article,Nashville;Nashville,1,Journal,2-s2.0-0034089566
Jones M.K.,,Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing,1999,Nature Medicine,768,10.1038/70995,United States,Article,Long Beach,0,Journal,2-s2.0-0032750920
Kensler T.,,United States-Japan workshop on new rodent models for the analysis and prevention of carcinogenesis,1999,Cancer Epidemiology Biomarkers and Prevention,2,,United States,Conference Paper,Baltimore,0,Journal,2-s2.0-0032724242
Peterson W.,,COX-1-sparing NSAIDs - Is the enthusiasm justified?,1999,Journal of the American Medical Association,93,10.1001/jama.282.20.1961,United States,Editorial,Dallas,0,Journal,2-s2.0-0033601084
Langman M.,,Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs,1999,Journal of the American Medical Association,659,10.1001/jama.282.20.1929,United Kingdom,Article,Birmingham,1,Journal,2-s2.0-0033601079
Mohammed S.,,Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder,1999,Cancer Research,268,,United States,Article,West Lafayette,0,Journal,2-s2.0-0033571143
He T.,,PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs,1999,Cell,994,10.1016/S0092-8674(00)81664-5,United States,Article,Baltimore,1,Journal,2-s2.0-0033615352
Langenbach R.,,Cyclooxygenase knockout mice Models for elucidating isoform-specific functions,1999,Biochemical Pharmacology,195,10.1016/S0006-2952(99)00158-6,United States,Article,Research Triangle Park,0,Journal,2-s2.0-0032839061
Shechan K.,,The relationship between cyclooxygenase-2 expression and colorectal cancer,1999,Journal of the American Medical Association,419,10.1001/jama.282.13.1254,Ireland;Ireland,Article,Dublin;Dublin,1,Journal,2-s2.0-0033530260
Yamamoto Y.,,Sulindac inhibits activation of the NF-κB pathway,1999,Journal of Biological Chemistry,467,10.1074/jbc.274.38.27307,United States,Article,Dallas,1,Journal,2-s2.0-0033578879
Collet J.,,Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: Effects of dosage and timing,1999,British Journal of Cancer,133,10.1038/sj.bjc.6690651,Canada;Canada,Article,Montreal;Montreal,1,Journal,2-s2.0-0032850948
Milas L.,,Enhancement of tumor response to γ-radiation by an inhibitor of cyclooxygenase-2 enzyme,1999,Journal of the National Cancer Institute,211,10.1093/jnci/91.17.1501,United States,Article,Houston,1,Journal,2-s2.0-0033199927
Molina M.,,Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs,1999,Cancer Research,407,,United States,Article,Houston,0,Journal,2-s2.0-0033199017
Tremblay C.,,Induction of prostaglandin G/H synthase-2 in a canine model of spontaneous prostatic adenocarcinoma,1999,Journal of the National Cancer Institute,51,10.1093/jnci/91.16.1398,,Article,,1,Journal,2-s2.0-0033581177
Fischer S.M.,,"Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis",1999,Molecular Carcinogenesis,359,10.1002/(SICI)1098-2744(199908)25:4<231::AID-MC1>3.0.CO;2-F,United States,Article,Smithville,0,Journal,2-s2.0-0032815072
Reddy B.,,Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process,1999,Cancer Research,103,,United States,Article,New York,0,Journal,2-s2.0-0033565252
Holash J.,,"Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF",1999,Science,1772,10.1126/science.284.5422.1994,United States,Article,Tarrytown,0,Journal,2-s2.0-0033580889
Wolfe M.,,Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs,1999,New England Journal of Medicine,1809,10.1056/NEJM199906173402407,United States;United States,Review,Boston;Boston,0,Journal,2-s2.0-0033577982
Catella-Lawson F.,,"Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids",1999,Journal of Pharmacology and Experimental Therapeutics,595,,United States,Conference Paper,Philadelphia,0,Journal,2-s2.0-0032948948
Smalley W.,,Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: A population-based study,1999,Archives of Internal Medicine,274,10.1001/archinte.159.2.161,United States;United States;United States,Article,Nashville;;Nashville,1,Journal,2-s2.0-0033601773
Mahmoud N.N.,,Genotype-phenotype correlation in murine Apc mutation: Differences in enterocyte migration and response to sulindac,1999,Cancer Research,56,,United States,Article,New York,0,Journal,2-s2.0-0033556002
Mcadam B.,,Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2,1999,Proceedings of the National Academy of Sciences of the United States of America,1134,10.1073/pnas.96.1.272,United States;United States,Article,Nashville;Philadelphia,1,Journal,2-s2.0-0033524421
Barnes C.J.,,"Determination of an optimal dosing regimen for aspirin chemoprevention of 1,2-dimethylhydrazine-induced colon tumours in rats",1999,British Journal of Cancer,14,10.1038/sj.bjc.6690263,United States,Article,San Antonio,1,Journal,2-s2.0-0033041892
Li H.,,"Prevention by aspirin and its combination with α-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E<inf>2</inf> levels in rat colon",1999,Carcinogenesis,83,10.1093/carcin/20.3.425,United States,Article,Toledo,1,Journal,2-s2.0-0032993593
Agarwal B.,,Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac,1999,Gastroenterology,183,10.1016/S0016-5085(99)70342-2,United States,Article,New York,0,Journal,2-s2.0-0032859782
Harris R.E.,,Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer,1999,Oncology Reports,171,10.3892/or.6.1.71,United States;United States,Article,Columbus;Columbus,0,Journal,2-s2.0-0032622310
Cullen L.,,Selective cyclooxygenase-2 inhibition by nimesulide in man,1998,Journal of Pharmacology and Experimental Therapeutics,139,,Ireland,Article,Dublin,0,Journal,2-s2.0-0032462418
Rioux N.,,Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398,1998,Cancer Research,192,,Canada,Article,Quebec,0,Journal,2-s2.0-0032403140
Taketo M.,,Cyclooxygenase-2 inhibitors in tumorigenesis (Part II),1998,Journal of the National Cancer Institute,490,10.1093/jnci/90.21.1609,Japan,Review,Tokyo,1,Journal,2-s2.0-0032483712
Fujita T.,,Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas,1998,Cancer Research,269,,Japan,Article,Tokyo,0,Journal,2-s2.0-0032212487
Rodriguez C.,,Paracetamol and risk of ovarian cancer mortality in a prospective study of women in the USA,1998,Lancet,32,10.1016/S0140-6736(05)60745-3,United States,Article,Atlanta,0,Journal,2-s2.0-0032564187
Taketo M.,,Cyclooxygenase-2 inhibitors in tumorigenesis (Part I),1998,Journal of the National Cancer Institute,483,10.1093/jnci/90.20.1529,Japan,Review,Tokyo,1,Journal,2-s2.0-0032556188
Carbone P.P.,,Phase I chemoprevention study of piroxicam and α- difluoromethylornithine,1998,Cancer Epidemiology Biomarkers and Prevention,43,,United States;United States;United States,Article,Madison;Madison;Madison,0,Journal,2-s2.0-0031661696
He T.C.,,Identification of c-MYC as a target of the APC pathway,1998,Science,3794,10.1126/science.281.5382.1509,,Article,,0,Journal,2-s2.0-0032483439
Norrish A.,,Non-steroidal anti-inflammatory drugs and prostate cancer progression,1998,International Journal of Cancer,158,10.1002/(SICI)1097-0215(19980812)77:4<511::AID-IJC6>3.0.CO;2-X,New Zealand,Article,Auckland,1,Journal,2-s2.0-0031823804
Okajima E.,,"Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N(4-hydroxybutyl) nitrosamine",1998,Cancer Research,133,,Japan,Article,Kashihara,0,Journal,2-s2.0-0032528189
Rosenberg L.,,Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma,1998,Cancer,150,10.1002/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q,United States,Article,Boston,1,Journal,2-s2.0-0032526038
Hansson L.,,Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial,1998,Lancet,5171,10.1016/S0140-6736(98)04311-6,Sweden,Article,Uppsala,0,Journal,2-s2.0-0032513878
Tsujii M.,,Cyclooxygenase regulates angiogenesis induced by colon cancer cells,1998,Cell,2141,10.1016/S0092-8674(00)81433-6,Japan,Article,Suita,1,Journal,2-s2.0-0003504049
Kawamori T.,,"Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis",1998,Cancer Research,913,,United States,Article,New York,0,Journal,2-s2.0-0032006784
Meade T.W.,,Thrombosis prevention trial: Randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk,1998,Lancet,782,10.1016/S0140-6736(97)11475-1,United Kingdom,Article,London,0,Journal,2-s2.0-0032562005
Chan T.,,Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis,1998,Proceedings of the National Academy of Sciences of the United States of America,552,10.1073/pnas.95.2.681,United States,Article,Baltimore,1,Journal,2-s2.0-0031882916
Cramer D.,,Over-the-counter analgesics and risk of ovarian cancer,1998,Lancet,204,10.1016/S0140-6736(97)08064-1,United States;United States,Article,Boston;Boston,0,Journal,2-s2.0-0032501741
Friedman G.D.,,Drugs and colon cancer,1998,Pharmacoepidemiology and Drug Safety,51,10.1002/(SICI)1099-1557(199803/04)7:2<99::AID-PDS320>3.0.CO;2-0,United States,Article,Oakland,0,Journal,2-s2.0-0031800897
Mahmoud N.N.,,Aspirin prevents tumors in a murine model of familial adenomatous polyposis,1998,Surgery,108,10.1016/S0039-6060(98)70124-2,United States,Article,New York,0,Journal,2-s2.0-0031856415
Sandler R.,,Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas,1998,Gastroenterology,135,10.1016/S0016-5085(98)70526-8,United States,Article,Chapel Hill,0,Journal,2-s2.0-0031888471
Schwenger P.,,Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IκBα phosphorylation and degradation,1998,Molecular and Cellular Biology,182,10.1128/mcb.18.1.78,United States,Article,New York,1,Journal,2-s2.0-0031982964
Hong W.,,Recent advances in chemoprevention of cancer,1997,Science,769,10.1126/science.278.5340.1073,,Review,,0,Journal,2-s2.0-0000147542
Chiu C.,,Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis,1997,Cancer Research,171,,United States,Article,Knoxville,0,Journal,2-s2.0-0030758925
Elder D.J.E.,,Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: Independence from COX-2 protein expression,1997,Clinical Cancer Research,369,,United Kingdom,Article,Bristol,0,Journal,2-s2.0-0030879456
Ruffin IV M.T.,,Suppression of human colorectal mucosal prostaglandins: Determining the lowest effective aspirin dose,1997,Journal of the National Cancer Institute,89,10.1093/jnci/89.15.1152,United States,Article,Ann Arbor,1,Journal,2-s2.0-0030851487
Piazza G.A.,,Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels,1997,Cancer Research,343,,United States,Article,Denver,0,Journal,2-s2.0-0030747817
Duperron C.,,Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice,1997,Carcinogenesis,133,10.1093/carcin/18.5.1001,Canada,Article,Quebec,1,Journal,2-s2.0-0031416517
Samaha H.,,"Modulation of apoptosis by sulindac, curcumin, phenylethyl-3- methylcaffeate, and 6-phenylhexyl isothiocyanate: Apoptotic index as a biomarker in colon cancer chemoprevention and promotion",1997,Cancer Research,286,,United States,Article,New York,0,Journal,2-s2.0-0031000902
Ristimäki A.,,Expression of cyclooxygenase-2 in human gastric carcinoma,1997,Cancer Research,806,,Finland;Finland,Article,Helsinki;Helsinki,0,Journal,2-s2.0-0141854494
Schwenger P.,,Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation,1997,Proceedings of the National Academy of Sciences of the United States of America,246,10.1073/pnas.94.7.2869,United States,Article,New York,1,Journal,2-s2.0-0031004569
La Vecchia C.,,Aspirin and colorectal cancer,1997,British Journal of Cancer,84,10.1038/bjc.1997.444,Italy;Italy,Article,Milan;Milan,1,Journal,2-s2.0-0030873152
Reeves M.,,Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women,1996,Cancer Epidemiology Biomarkers and Prevention,103,,United States;United States;United States,Article,Lansing;Atlanta;Madison,0,Journal,2-s2.0-0029829551
Reddy B.,,Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis,1996,Cancer Research,416,,United States,Article,New York,0,Journal,2-s2.0-0029794742
Kauppi M.,,Low incidence of colorectal cancer in patients with rheumatoid arthritis,1996,Clinical and Experimental Rheumatology,60,,Finland,Article,Heinola,0,Journal,2-s2.0-0029809823
Peleg I.I.,,Long-term use of nonsteroidal antiinflammatory drugs and other chemopreventors and risk of subsequent colorectal neoplasia,1996,Digestive Diseases and Sciences,95,10.1007/BF02088554,United States,Article,Iowa City,0,Journal,2-s2.0-0030017494
Morin P.,,Apoptosis and APC in colorectal tumorigenesis,1996,Proceedings of the National Academy of Sciences of the United States of America,414,10.1073/pnas.93.15.7950,United States;United States,Article,Baltimore;Chevy Chase,1,Journal,2-s2.0-0029799144
Egan K.,,Prospective study of regular aspirin use and the risk of breast cancer,1996,Journal of the National Cancer Institute,169,10.1093/jnci/88.14.988,United States;United States,Article,Boston;Boston,1,Journal,2-s2.0-0029998249
Boolbol S.,,Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis,1996,Cancer Research,532,,United States;United States,Article,New York;New York,0,Journal,2-s2.0-9344257283
Pereira M.,,Piroxicam-induced regression of azoxymethane-induced aberrant crypt foci and prevention of colon cancer in rats,1996,Carcinogenesis,40,10.1093/carcin/17.2.373,United States;United States,Article,Toledo;Lexington,1,Journal,2-s2.0-0029927003
Takahashi M.,,"Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2",1996,Journal of Cancer Research and Clinical Oncology,69,10.1007/BF01209649,Japan,Article,Chuo-ku,0,Journal,2-s2.0-0029939286
DuBois R.,,G<inf>1</inf> delay in cells overexpressing prostaglandin endoperoxide synthase-2,1996,Cancer Research,182,,United States;United States,Article,Nashville;,0,Journal,2-s2.0-0029664607
Shiff S.,,Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: Effects on cell cycle and apoptosis,1996,Experimental Cell Research,323,10.1006/excr.1996.0023,United States;United States,Article,New York;New York,0,Journal,2-s2.0-0030038519
Giardiello F.,,NSAID-induced polyp regression in familial adenomatous polyposis patients,1996,Gastroenterology Clinics of North America,40,10.1016/S0889-8553(05)70251-X,United States,Article,Baltimore,0,Journal,2-s2.0-0029896486
Masferrer J.,,Cyclooxygenase-2 inhibitors: A new class of anti-inflammatory agents that spare the gastrointestinal tract,1996,Gastroenterology Clinics of North America,115,10.1016/S0889-8553(05)70252-1,United States,Article,New York,0,Journal,2-s2.0-0029977379
Bansal P.,,Risk factors of colorectal cancer in inflammatory bowel disease,1996,American Journal of Gastroenterology,171,,,Article,,0,Journal,2-s2.0-0030027701
Smith W.L.,,Prostaglandin endoperoxide H syntheses (cyclooxygenases)-1 and -2,1996,Journal of Biological Chemistry,1770,10.1074/jbc.271.52.33157,United States,Article,East Lansing,1,Journal,2-s2.0-0030479496
Langenbach R.,,Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration,1995,Cell,989,10.1016/0092-8674(95)90126-4,United States,Article,Research Triangle Park,1,Journal,2-s2.0-0028843881
Tsujii M.,,Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2,1995,Cell,2080,10.1016/0092-8674(95)90127-2,United States,Article,,1,Journal,2-s2.0-0028803728
Martínez M.,,Aspirin and Other Nonsteroidal Anti-Inflammatory Drugs and Risk of Colorectal Adenomatous Polyps Among Endoscoped Individuals,1995,Cancer Epidemiology Biomarkers and Prevention,82,,United States,Article,Houston,0,Journal,2-s2.0-0028843830
Marcus A.,,Aspirin as prophylaxis against colorectal cancer,1995,New England Journal of Medicine,71,10.1056/NEJM199509073331011,United States,Editorial,,0,Journal,2-s2.0-0029148381
Giovannucci E.,,Aspirin and the risk of colorectal cancer in women,1995,New England Journal of Medicine,940,10.1056/NEJM199509073331001,,Article,,0,Journal,2-s2.0-0029150934
Piazza G.,,Antineoplastic Drugs Sulindac Sulfide and Sulfone Inhibit Cell Growth by Inducing Apoptosis,1995,Cancer Research,432,,United States,Article,Denver,0,Journal,2-s2.0-0029035070
Bedi A.,,Inhibition of Apoptosis during Development of Colorectal Cancer,1995,Cancer Research,546,,United States,Article,Baltimore,0,Journal,2-s2.0-0028941441
Giovannucci E.,,"Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men",1995,Journal of the National Cancer Institute,563,10.1093/jnci/87.4.265,United States,Article,Boston,0,Journal,2-s2.0-0028921519
Thun M.,,Aspirin use and reduced risk of gastrointestinal tract cancers in the American Cancer Society Prospective Studies,1995,Preventive Medicine,19,10.1006/pmed.1995.1021,United States,Article,Atlanta,0,Journal,2-s2.0-0028902179
Paganini-Hill A.,,Aspirin and colorectal cancer: The Leisure World Cohort revisited,1995,Preventive Medicine,34,10.1006/pmed.1995.1020,United States,Article,Los Angeles,0,Journal,2-s2.0-0028946407
Wargovich M.,,Inhibition of aberrant crypt growth by non‐steroidal anti‐inflammatory agents and differentiation agents in the rat colon,1995,International Journal of Cancer,95,10.1002/ijc.2910600415,United States,Article,Houston,0,Journal,2-s2.0-0028924867
Lynch H.,,Rectal cancer after prolonged sulindac chemoprevention. A case report,1995,Cancer,94,10.1002/1097-0142(19950215)75:4<936::AID-CNCR2820750407>3.0.CO;2-Q,United States,Article,Omaha,1,Journal,2-s2.0-0028813830
Ladenheim J.,,Effect of sulindac on sporadic colonic polyps,1995,Gastroenterology,107,10.1016/0016-5085(95)90206-6,United States,Article,Stanford,0,Journal,2-s2.0-0028921222
Pasricha P.,,The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis,1995,Gastroenterology,229,10.1016/0016-5085(95)90411-5,United States,Article,Baltimore,0,Journal,2-s2.0-0029088472
Shiff S.,,"Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells",1995,Journal of Clinical Investigation,402,10.1172/JCI118060,United States;United States,Article,New York;New York,1,Journal,2-s2.0-0029115954
Rao C.,,"Chemoprevention of Colon Carcinogenesis by Sulindac, a Nonsteroidal Anti-inflammatory Agent",1995,Cancer Research,398,,United States,Article,Bethesda,0,Journal,2-s2.0-0028904461
Thun M.,,"Aspirin, NSAIDs, and digestive tract cancers",1994,Cancer and Metastasis Reviews,78,10.1007/BF00666097,United States,Article,Atlanta,0,Journal,2-s2.0-0028576835
Müller A.,,Diseases preceding colon cancer - A case-control study among veterans,1994,Digestive Diseases and Sciences,53,10.1007/BF02087670,United States,Article,Milwaukee,0,Journal,2-s2.0-0028092123
Giovannucci E.,,Aspirin use and the risk for colorectal cancer and adenoma in male health professionals,1994,Annals of Internal Medicine,699,10.7326/0003-4819-121-4-199408150-00001,United States,Article,Boston,0,Journal,2-s2.0-0028556801
Wood A.,,Aspirin as an antiplatelet drug,1994,New England Journal of Medicine,804,10.1056/NEJM199405053301808,,Review,,0,Journal,2-s2.0-0028354308
Peleg I.,,Aspirin and Nonsteroidal Anti-inflammatory Drug Use and the Risk of Subsequent Colorectal Cancer,1994,Archives of Internal Medicine,211,10.1001/archinte.1994.00420040050009,United States,Article,Atlanta,0,Journal,2-s2.0-0028344925
Altman R.,,"Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients",1994,British Medical Journal,3560,,United Kingdom,Review,Oxford,0,Journal,2-s2.0-0028120906
Mereto E.,,"Effect of aspirin on incidence and growth of aberrant crypt foci induced in the rat colon by 1,2-dimethylhydrazine",1994,Cancer Letters,47,10.1016/0304-3835(94)90127-9,Italy,Article,Genoa,0,Journal,2-s2.0-0028107160
Davis A.E.,,Aspirin reduces the incidence of colonic carcinoma in the dimethylhydrazine rat animal model,1994,Australian and New Zealand Journal of Medicine,26,10.1111/j.1445-5994.1994.tb02176.x,Australia,Article,Sydney,0,Journal,2-s2.0-0028452329
Muscat J.,,Nonsteroidal antiinflammatory drugs and colorectal cancer,1994,Cancer,200,10.1002/1097-0142(19941001)74:7<1847::AID-CNCR2820740704>3.0.CO;2-#,United States,Article,New York,0,Journal,2-s2.0-0028085411
Giovannucci E.,,Dietary factors and risk of colon cancer,1994,Annals of Medicine,266,10.3109/07853899409148367,United States;United States,Article,Boston;Boston,0,Journal,2-s2.0-0028576901
Pinczowski D.,,Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study,1994,Gastroenterology,327,10.1016/0016-5085(94)90068-X,Sweden;Sweden,Article,Uppsala;Stockholm,0,Journal,2-s2.0-0028305575
Schreinemachers D.,,"Aspirin use and lung, colon, and breast cancer incidence in a prospective study",1994,Epidemiology,691,10.1097/00001648-199403000-00003,United States,Article,Research Triangle Park,0,Journal,2-s2.0-0028325496
Kopp E.,,Inhibition of NF-κB by sodium salicylate and aspirin,1994,Science,1521,10.1126/science.8052854,United States,Article,New Haven,0,Journal,2-s2.0-0028167846
Eberhart C.,,Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas,1994,Gastroenterology,2242,10.1016/0016-5085(94)90246-1,United States,Article,Nashville,0,Journal,2-s2.0-0027993458
Tonelli F.,,Sulindac in familial adenomatous polyposis,1993,The Lancet,34,10.1016/0140-6736(93)92108-6,Italy,Letter,Florence,0,Journal,2-s2.0-0027491687
Klän R.,,Acetylsalicylic acid inhibition of n-butyl-(4-hydroxybutyl) nitrosamine-induced bladder carcinogenesis in rats,1993,Journal of Cancer Research and Clinical Oncology,33,10.1007/BF01215929,Germany,Article,Berlin,0,Journal,2-s2.0-0027286057
Reddy B.,,Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in f344 rats,1993,Carcinogenesis,334,10.1093/carcin/14.8.1493,United States,Article,New York,0,Journal,2-s2.0-0027183769
Shibata M.,,Modification of BHA forestomach carcinogenesis in rats: Inhibition by diethylmaleate or indomethacin and enhancement by a retinoid,1993,Carcinogenesis,14,10.1093/carcin/14.7.1265,Japan,Article,Nagoya,0,Journal,2-s2.0-0027250272
Greenberg E.R.,,Reduced risk of large-bowel adenomas among aspirin users,1993,Journal of the National Cancer Institute,280,10.1093/jnci/85.11.912,United States,Article,Hanover,0,Journal,2-s2.0-0027245529
Giardiello F.,,Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous Polyposis,1993,New England Journal of Medicine,1477,10.1056/NEJM199305063281805,United States,Article,Baltimore,0,Journal,2-s2.0-0027197062
Gridley G.,,Incidence of cancer among patients with rheumatoid arthritis,1993,Journal of the National Cancer Institute,561,10.1093/jnci/85.4.307,United States,Article,Bethesda,0,Journal,2-s2.0-0027528555
Logan R.F.A.,,Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: Case-control study of subjects participating in the Nottingham faecal occult blood screening programme,1993,British Medical Journal,233,10.1136/bmj.307.6899.285,United Kingdom,Article,Nottingham,1,Journal,2-s2.0-0027237664
Suh O.,,"Aspirin use, cancer, and polyps of the large bowel",1993,Cancer,269,10.1002/1097-0142(19930815)72:4<1171::AID-CNCR2820720407>3.0.CO;2-D,United States,Article,Buffalo,0,Journal,2-s2.0-0027291812
Nugent K.,,Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis,1993,British Journal of Surgery,410,10.1002/bjs.1800801244,United Kingdom,Article,Harrow,0,Journal,2-s2.0-0027141503
Thun M.,,Aspirin Use and Risk of Fatal Cancer,1993,Cancer Research,847,,United States;United States,Article,Atlanta;Atlanta,0,Journal,2-s2.0-0027512524
Reddy B.,,Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds,1992,Carcinogenesis,148,10.1093/carcin/13.6.1019,United States,Article,New York,0,Journal,2-s2.0-0026643184
Craven P.,,"Effects of aspirin on 1, 2-dimethylhydrazine-induced colonic carcinogenesis",1992,Carcinogenesis,123,10.1093/carcin/13.4.541,United States,Article,Pittsburgh,0,Journal,2-s2.0-0026572734
Xie W.,,Mitogen‐inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs,1992,Drug Development Research,318,10.1002/ddr.430250402,United States,Review,Provo,0,Journal,2-s2.0-0026588961
Thun M.,,Aspirin use and reduced risk of fatal colon cancer,1991,New England Journal of Medicine,1589,10.1056/NEJM199112053252301,United States,Article,Atlanta,0,Journal,2-s2.0-0025998557
Paganini-hill A.,,Aspirin use and incidence of large-bowel cancer in a California retirement community,1991,Journal of the National Cancer Institute,72,10.1093/jnci/83.16.1182-a,United States,Letter,Los Angeles,1,Journal,2-s2.0-0025744852
Rosenberg L.,,A hypothesis: Nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer,1991,Journal of the National Cancer Institute,513,10.1093/jnci/83.5.355,United States,Article,Boston,0,Journal,2-s2.0-0026417761
Skinner S.,,Sulindac Inhibits the Rate of Growth and Appearance of Colon Tumors in the Rat,1991,Archives of Surgery,85,10.1001/archsurg.1991.01410330048007,Australia,Article,Melbourne,0,Journal,2-s2.0-0026075136
Rao C.,,"Chemoprevention of Colon Carcinogenesis by Dietary Administration of Piroxicam, a-Difluoromethylornithine, 16a-Fluoro-5-androsten-17-one, and Ellagic Acid Individually and in Combination",1991,Cancer Research,205,,United States;United States,Article,New York;Bethesda,0,Journal,2-s2.0-0025999819
Labayle D.,,Sulindac causes regression of rectal polyps in familial adenomatous polyposis,1991,Gastroenterology,625,10.1016/0016-5085(91)90519-Q,France;France;France;France;France;France;France,Article,Beziers;Evry;Argenteuil;Paris;Le Kremlin-Bicetre;Orleans;Beauvais,0,Journal,2-s2.0-0025834849
Reddy B.,,"Chemoprevention of Colon Carcinogenesis by Concurrent Administration of Piroxicam, a Nonsteroidal Antiinflammatory Drug with d,l-α Difluoromethylornithine, an Ornithine Decarboxylase Inhibitor, in Diet",1990,Cancer Research,244,,United States,Article,New York,0,Journal,2-s2.0-0025270332
Moorghen M.,,The effect of sulindac on colonic tumour formation in dimethylhydrazine-treated mice.,1990,Acta histochemica. Supplementband,21,,United Kingdom,Article,Newcastle,0,Journal,2-s2.0-0025653385
Vane J.,,History of aspirin and its mechanism of action,1990,Stroke,157,,United Kingdom,Article,London,0,Journal,2-s2.0-0025694966
Pollard M.,,Prevention and Treatment of Primary Intestinal Tumors in Rats by Piroxicam,1989,Cancer Research,45,,United States,Article,Notre Dame,0,Journal,2-s2.0-0024331456
,,Final Report on the Aspirin Component of the Ongoing Physicians' Health Study,1989,New England Journal of Medicine,2254,10.1056/NEJM198907203210301,,Article,,0,Journal,2-s2.0-0024406369
Paganini-Hill A.,,Aspirin use and chronic diseases: A cohort study of the elderly,1989,British Medical Journal,358,10.1136/bmj.299.6710.1247,United States,Article,Los Angeles,1,Journal,2-s2.0-0024418625
Moorghen M.,,A protective effect of sulindac against chemically‐induced primary colonic tumours in mice,1988,The Journal of Pathology,146,10.1002/path.1711560411,United Kingdom,Article,Newcastle,0,Journal,2-s2.0-0024211723
Kune G.,,"Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the melbourne colorectal cancer study",1988,Cancer Research,628,,Australia,Article,Parkville,0,Journal,2-s2.0-0023687241
Lehnert T.,,"Effect of flurbiprofen and 16,16-dimethyl-prostaglandin E<inf>2</inf> on gastrointestinal tumorigenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats. I. Squamous epithelium and mesenchymal tissue",1987,Journal of the National Cancer Institute,11,,United States,Article,New York,0,Journal,2-s2.0-0023202424
Reddy R.,,"Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development",1987,Cancer Research,315,,United States,Article,New York,0,Journal,2-s2.0-0023270948
Botha J.,,"Human esophageal carcinoma cell lines: Prostaglandin production, biological properties, and behavior in nude mice",1986,Journal of the National Cancer Institute,36,10.1093/jnci/76.6.1053,South Africa,Article,Durban,0,Journal,2-s2.0-0022593177
Nigro N.D.,,Inhibition of intestinal carcinogenesis in rats: Effect of difluoromethylornithine with piroxicam or fish oil,1986,Journal of the National Cancer Institute,121,10.1093/jnci/77.6.1309,United States,Article,Detroit,0,Journal,2-s2.0-0022910889
Narisawa T.,,Reduction of carcinogenicity of N-nitrosomethylurea by indomethacin and failure of resuming effect of prostaglandin E<inf>2</inf> (PGE<inf>2</inf>) against indomethacin,1984,Journal of Cancer Research and Clinical Oncology,46,10.1007/BF00402475,Germany,Article,Heidelberg,0,Journal,2-s2.0-0021229118
Metzger U.,,Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer,1984,Diseases of the Colon &amp; Rectum,73,10.1007/BF02553001,Switzerland,Article,Zurich,0,Journal,2-s2.0-0021140875
Pollard M.,,Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea,1984,Cancer Letters,91,10.1016/S0304-3835(84)80035-X,United States,Article,Notre Dame,0,Journal,2-s2.0-0021717637
Narisawa T.,,Inhibition of initiation and promotion by N-methylnitrosourea-induced colon carcinogenesis in rats by non-steroid anti-inflammatory agent indomethacin,1983,Carcinogenesis,89,10.1093/carcin/4.10.1225,Japan,Article,Akita,0,Journal,2-s2.0-0021050635
Pollard M.,,The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat,1983,Cancer Letters,93,10.1016/0304-3835(83)90082-4,United States,Article,Notre Dame,0,Journal,2-s2.0-0021051198
Pollard M.,,Prolonged antitumor effect of indomethacin on autochthonous intestinal tumors in rats,1983,Journal of the National Cancer Institute,104,,United States,Article,Notre Dame,0,Journal,2-s2.0-0020616992
FitzGerald G.,,Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man,1983,Journal of Clinical Investigation,510,10.1172/JCI110814,United States,Article,Nashville,0,,2-s2.0-0020692577
Narisawa T.,,Inhibition of development of methylnitrosourea-induced rat colonic-tumors by peroral administration of indomethacin,1982,"Gann, The Japanese Journal of Cancer Research",46,,Japan,Article,Akita,0,Journal,2-s2.0-0019979089
Patrignani P.,,Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects,1982,Journal of Clinical Investigation,744,10.1172/JCI110576,Italy,Article,Rome,1,Journal,2-s2.0-0019988413
Takahashi T.,,Inhibition of Development of Methylnitrosourea-Induced Rat Colon Tumors by Indomethacin Treatment,1981,Cancer Research,236,,Japan;Japan,Article,Akita;Akita,0,Journal,2-s2.0-0019428705
Pollard M.,,Treatment of Chemically-Induced Intestinal Cancers with Indomethacin,1981,Proceedings of the Society for Experimental Biology and Medicine,57,10.3181/00379727-167-41142,United States,Article,Notre Dame,0,Journal,2-s2.0-0019870897
Pollard M.,,Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine,1981,Science,153,10.1126/science.7291992,United States,Article,Notre Dame,0,Journal,2-s2.0-0019792996
Pollard M.,,Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors,1980,Cancer Treatment Reports,141,,United States,Article,Notre Dame,0,Journal,2-s2.0-0019301163
Kudo T.,,Antitumor activity of indomethacin on methylazoxymethanol-induced large bowel tumors in rats,1980,"Gann, The Japanese Journal of Cancer Research",115,,Japan,Article,Akita,0,Journal,2-s2.0-0018876770
Friedman G.,,Initial screening for carcinogenicity of commonly used drugs,1980,Journal of the National Cancer Institute,135,10.1093/jnci/65.4.723,United States,Article,CA,0,Journal,2-s2.0-0018822553
Pollard M.,,"Induction of Colon Tumors in 1, 2-Dimethylhydrazine-Resistant Lobund Wistar Rats by Methylazoxymethanol Acetate",1978,Journal of the National Cancer Institute,23,10.1093/jnci/61.2.493,United States,Article,Notre Dame,0,Journal,2-s2.0-0018187392
Isomäki H.,,"Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis",1978,Journal of Chronic Diseases,381,10.1016/0021-9681(78)90071-1,Finland,Article,Heinola,0,Journal,2-s2.0-0018110856
Weisburger J.,,Colo rectal cancer,1975,U.I.C.C. Technical Report Series,21,,Switzerland,Article,Geneve,0,Journal,2-s2.0-0016777771
Bennett A.,,Prostaglandins in human colonic carcinoma,1975,Gut,86,,United Kingdom,Article,London,0,Journal,2-s2.0-0016505089
Jaffe B.,,Prostaglandins and cancer: An update,1974,Prostaglandins,152,10.1016/S0090-6980(74)80055-9,United States,Article,St. Louis,0,Journal,2-s2.0-0016185262
Vane J.,,Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs,1971,Nature New Biology,6940,10.1038/newbio231232a0,United Kingdom,Article,London,0,Journal,2-s2.0-0015237292
